OMEGA THERAPEUTICS, INC.

(OMGA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about OMEGA THERAPEUTICS, INC.
05/06Wedbush Adjusts Price Target on Omega Therapeutics to $24 From $30, Keeps Outperform Ra..
MT
05/04Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
04/29Omega Therapeutics Hires Aldeyra Therapeutics Chief Financial Officer Joshua Reed for S..
MT
04/29Omega Therapeutics Announces Appointment of Joshua Reed as Chief Financial Officer
PR
04/29Omega Therapeutics Announces Appoints Joshua Reed as Chief Financial Officer, Effective..
CI
04/29Omega Therapeutics, Inc. Announces Executive Changes
CI
03/30Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Gro..
PR
03/30Omega Therapeutics Inc. Announces Executive Changes
CI
03/11Wedbush Adjusts Omega Therapeutics' Price Target to $30 From $36, Keeps Outperform Rati..
MT
03/10SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Thursday
MT
03/10SECTOR UPDATE : Health Care
MT
03/10OMEGA THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results and Outli..
PU
03/10Omega Therapeutics Q4 Net Loss Narrows
MT
03/10Omega Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December..
CI
03/10Omega Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, ..
CI
01/26Certain Common Stock of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement End..
CI
01/26Certain Stock Options of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement E..
CI
01/26Certain Warrants of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement Ending ..
CI
01/10Omega Therapeutics Announces Appointment of Yan Moore, M.D., as Chief Medical Officer
PR
01/10Omega Therapeutics Announces Appointment of Yan Moore as Chief Medical Officer
CI
2021Omega Therapeutics, Inc. and Pacific Western Bank Enters into the Fourth Amendment to t..
CI
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to S&P Global BMI Index
CI
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to NASDAQ Biotechnology Index
CI
2021Omega Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare C..
PR
2021Omega Therapeutics Narrows Loss in Q3
MT
2021Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor..
PU
2021Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor..
PR
2021Omega Therapeutics to Present at the Jefferies London Healthcare Conference
PR
2021OMEGA THERAPEUTICS : Working With Stanford University to Explore Use of Omega Epigenomic C..
MT
2021OMEGA THERAPEUTICS : Announces Strategic Research Collaboration with Stanford University S..
PR
2021Omega Therapeutics, Inc. Announces Strategic Research Collaboration with Stanford Unive..
CI
2021TRANSCRIPT : Omega Therapeutics, Inc. Presents at Chardan's 5th Annual Genetic Medicines C..
CI
2021OMEGA THERAPEUTICS : to Present at the Chardan Virtual 5th Annual Genetic Medicines Confer..
PR
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to S&P TMI Index
CI
2021OMEGA THERAPEUTICS' : Q2 Loss Widens as Operating Expenses Rise
MT
2021OMEGA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Outlines Key Corpor..
PR
2021Omega Therapeutics, Inc. Announces Unaudited Earnings Results for the Second Quarter an..
CI
2021OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target
MT
2021OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Tar..
MT
2021OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price ..
MT
2021OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target
MT
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to NASDAQ Composite Index
CI
2021OMEGA THERAPEUTICS : Falls in Nasdaq Debut After Pricing IPO at Midpoint of Expected Range
MT
2021OMEGA THERAPEUTICS : Prices IPO at Midpoint of Expected Range at $17 Per Share
MT
2021OMEGA THERAPEUTICS : Announces Pricing of Initial Public Offering
PR
2021Omega Therapeutics, Inc. has completed an IPO in the amount of $125.8 million.
CI
2021Omega Therapeutics, Inc. has filed an IPO in the amount of $100 million.
CI